Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D5IS
|
|||
| Former ID |
DIB016104
|
|||
| Drug Name |
SYNSORB-Pk
|
|||
| Synonyms |
Verotoxin adsorbent; Chromosorb (hemolytic uremic syndrome); Hamburger disease therapy, SYNSORB; TAK-157F; TAK-7515; TAK-751S
Click to Show/Hide
|
|||
| Indication | Clostridium infection [ICD-11: 1A04; ICD-10: A04.7] | Phase 3 | [1] | |
| Company |
Alberta Research Council
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00004465) Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.